Integra Lifesciences Holdings Corp
NASDAQ:IART
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Integra Lifesciences Holdings Corp
NASDAQ:IART
|
US |
|
B
|
Baker Hughes Co
LSE:0RR8
|
US |
|
W
|
Wheaton Precious Metals Corp
F:SII
|
CA |
|
Preferred Bank
NASDAQ:PFBC
|
US |
|
E
|
Eni SpA
SWB:ENI
|
IT |
|
T
|
TransDigm Group Inc
F:T7D
|
US |
|
Cardinal Health Inc
NYSE:CAH
|
US |
Wall St Price Targets
IART Price Targets Summary
Integra Lifesciences Holdings Corp
According to Wall Street analysts, the average 1-year price target for IART is 17.54 USD with a low forecast of 14.14 USD and a high forecast of 28.35 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IART's stock price target?
Price Target
17.54
USD
According to Wall Street analysts, the average 1-year price target for IART is 17.54 USD with a low forecast of 14.14 USD and a high forecast of 28.35 USD.
What is the Revenue forecast for Integra Lifesciences Holdings Corp?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for Integra Lifesciences Holdings Corp?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Integra Lifesciences Holdings Corp?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 24%.
